Clobetasol propionate oral

丙酸氯倍他索口服剂

Report date: 2025/11/17 14:45:31

Base Information

Drug NameClobetasol propionate oral
Drug Alias NameRivelin Clobetasol patchRivelin-CLOAFYX-005
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsVulvar Lichen SclerosusOral UlcerLichen Planus, Oral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAfyx Therapeutics A/S
China Registration ClassN/A

Develop Information

Active CompaniesAfyx Therapeutics A/S
Inactive CompaniesN/A
Active IndicationsVulvar Lichen SclerosusOral UlcerLichen Planus, Oral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A